Variables | Response | P | |
---|---|---|---|
Grade 0, 1 | Grade 2, 3 | ||
Sex | |||
 Female | 12 | 2 | 1.00 |
 Male | 57 | 13 |  |
Age | |||
 Years | 65 (41–77) | 66 (30–76) | 0.56 |
cT | |||
 1 | 8 | 3 | 0.78 |
 2 | 10 | 2 |  |
 3 | 49 | 10 |  |
 4 | 2 | 0 |  |
cN | |||
 0 | 8 | 2 | 0.80 |
 1 | 38 | 9 |  |
 2 | 20 | 3 |  |
 3 | 3 | 1 |  |
cStage | |||
 1 | 2 | 1 | 0.75 |
 2 | 18 | 4 |  |
 3 | 45 | 9 |  |
 4 | 4 | 1 |  |
pT | |||
 0 | 0 | 4 | > 0.0001 |
 1 | 17 | 6 |  |
 2 | 15 | 4 |  |
 3 | 29 | 0 |  |
 4 | 8 | 1 |  |
pN | |||
 0 | 24 | 5 | 0.90 |
 1 | 22 | 6 |  |
 2 | 13 | 3 |  |
 3 | 10 | 1 |  |
pStage | |||
 0 | 0 | 2 | 0.07 |
 1 | 14 | 3 |  |
 2 | 21 | 6 |  |
 3 | 29 | 4 |  |
 4 | 5 | 0 |  |
Differentiation | |||
 Well or moderate | 56 | 11 | 0.340 |
 Poor | 10 | 0 |  |
Lymphatic invasion | |||
 < 2 | 23 | 8 | 0.250 |
 ≥ 2 | 46 | 7 |  |
Venous invasion | |||
 < 20 | 50 | 9 | 0.36 |
 ≥ 20 | 19 | 6 |  |
Pretreatment CEA | |||
 ng/ml | 2.6 (1.0–6.0) | 1.9 (0.4–4.3) | 0.060 |
Pretreatment SCC | |||
 ng/ml | 1.1 (0.5–6.4) | 1.4 (0.6–6.7) | 0.350 |